I appreciate your priceless attention and advice.
However, may I justify as follows:
While initial sequencing included three control replicates, unsupervised PCA revealed that control_6h_4 acted as a severe biological outlier, exhibiting extreme transcriptomic deviation from the stable baseline of the other controls. Because Nile tilapia are an outbred species, high inherent genetic and phenotypic variance occasionally results in uncharacteristic baseline deviations due to natural individual physiology or subclinical stress. Technically, retaining this outlier would have artificially inflated the intra-group dispersion estimates within DESeq2, causing a severe loss of statistical power and an unacceptable increase in false negative rates (masking true biological signals). Therefore, in accordance with standard transcriptomic quality control for outbred animal models, this sample was excluded prior to DEG calling to ensure the control baseline accurately reflected a stable, healthy physiological state. The robust discovery of 439 highly significant DEGs, subsequently validated by our in vivo qRT-PCR data, confirms that this refined baseline yielded highly reliable biological insights.
So, what is your further advice?
Great thanks